Laboratorio de Investigación de Productos Naturales, Escuela Superior de Ingeniería Química e Industrias Extractivas IPN, CP, Mexico.
Biol Pharm Bull. 2012;35(9):1516-24. doi: 10.1248/bpb.b12-00246.
In India, Azadirachta indica is typically known as 'neem tree' and its leaves has long been used in the ayurvedic medical tradition as a treatment for diabetes mellitus. In-depth chromatographic investigation on chloroform extract resulted in identification of one new tetranortriterpenoid. Structural elucidation was established on the basis of spectral data as 24,25,26,27-tetranor-apotirucalla-(apoeupha)-1α-senecioyloxy-3α,7α-dihydroxy-14,20,22-trien-21,23-epoxy named by us as meliacinolin (1). The present study investigated the effect hypoglycaemic, hypolipidemic, oxidative stress, insulin resistance, α-glucosidase and α-amylase of 1 from A. indica. Diabetic rats were treated with 1 for 28 d and a set of biochemical parameters were studied including: glucose level, total cholesterol, triglycerides, lipid peroxidation, liver and muscle glycogen, superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase. We also looked into liver function by determining glucose-6-phosphatase, glucokinase and hexokinase activities, and the effect on insulin level. While in vitro inhibition of α-glucosidase and α-amylase enzyme activities were used as indices of effect on glucose absorption. As a result we found that blood glucose level, serum biochemical parameters, hepatic enzymes, thiobarbituric acid reactive substances, and insulin level were restored in streptozotocin (STZ)-diabetic mice to normal levels with 1. Meliacinolin inhibited α-glucosidase and α-amylase activities. We conclude that meliacinolin can efficiently inhibit insulin resistance, improvement of renal function, lipid abnormalities, and oxidative stress, indicating that its therapeutic properties may be due to the interaction of meliacinolin with multiple targets involved in diabetes pathogenesis. α-Glucosidase and α-amylase inhibitors offer an effective strategy to lower the levels of post prandial hyperglycemia prevents the digestion of carbohydrates.
在印度,印楝通常被称为“尼姆树”,其叶子在印度阿育吠陀医学传统中一直被用作治疗糖尿病的药物。对氯仿提取物进行深入的色谱研究,结果鉴定出一种新的四环三萜。根据光谱数据,结构阐明为 24,25,26,27-四降-阿波桐拉-(阿朴脂)-1α-千里光酰氧基-3α,7α-二羟基-14,20,22-三烯-21,23-环氧,我们将其命名为美拉辛林(1)。本研究调查了来自印楝的 1 对降血糖、降血脂、氧化应激、胰岛素抵抗、α-葡萄糖苷酶和α-淀粉酶的作用。糖尿病大鼠用 1 治疗 28 天,研究了一组生化参数,包括:血糖水平、总胆固醇、甘油三酯、脂质过氧化、肝和肌肉糖原、超氧化物歧化酶、过氧化氢酶、谷胱甘肽过氧化物酶和谷胱甘肽还原酶。我们还通过测定葡萄糖-6-磷酸酶、葡激酶和己糖激酶的活性来研究肝功能,并观察对胰岛素水平的影响。同时,体外抑制α-葡萄糖苷酶和α-淀粉酶的酶活性被用作对葡萄糖吸收作用的指标。结果发现,1 可使链脲佐菌素(STZ)-糖尿病小鼠的血糖水平、血清生化参数、肝酶、硫代巴比妥酸反应物质和胰岛素水平恢复正常。美拉辛林抑制α-葡萄糖苷酶和α-淀粉酶的活性。我们得出结论,美拉辛林能有效抑制胰岛素抵抗、改善肾功能、脂质异常和氧化应激,表明其治疗特性可能是由于美拉辛林与参与糖尿病发病机制的多个靶点相互作用。α-葡萄糖苷酶和α-淀粉酶抑制剂提供了一种有效的策略,可以降低餐后高血糖水平,防止碳水化合物的消化。